Blastic Plasmacytoid Dendritic Cell Neoplasia (BPDC) in Elderly Patients: Results of a Treatment Algorithm Employing Allogeneic Stem Cell Transplantation with Moderately Reduced Conditioning Intensity-Reference-Cited by-同舟云学术

Blastic Plasmacytoid Dendritic Cell Neoplasia (BPDC) in Elderly Patients: Results of a Treatment Algorithm Employing Allogeneic Stem Cell Transplantation with Moderately Reduced Conditioning Intensity

Published:2011-08 Issue:8 Volume:17 Page:1250-1254
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Dietrich Sascha,Andrulis Mindaugas,Hegenbart Ute,Schmitt Thomas,Bellos Frauke,Martens Uwe M.,Meissner Julia,Krämer Alwin,Ho Anthony D.,Dreger Peter

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference14 articles.

1. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells;Herling;Am J Clin Pathol,2007

2. TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin;Herling;Blood,2003

3. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues;Swerdlow,2008

4. CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature;Bekkenk;Ann Oncol,2004

5. What is CD4+CD56+ malignancy and how should it be treated?;Reimer;Bone Marrow Transplant,2003

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tagraxofusp, a first‐in‐class CD123‐targeted agent: Five‐year postapproval comprehensive review of the literature;Cancer;2024-04-15

2. Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations;Leukemia & Lymphoma;2024-02-23

3. Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patients;eJHaem;2024-02

4. Breakthrough in Blastic Plasmacytoid Dendritic Cell Neoplasm Cancer Therapy Owing to Precision Targeting of CD123;International Journal of Molecular Sciences;2024-01-25

5. A rare case of Blastic plasmacytoid dendritic cell neoplasm with gynecologic presentation;Leukemia Research Reports;2024